By immunohistochemistry (IHC), the tumor cells showed strong reactivity for INSM1 and CHGA, and diffuse nuclear TP53 reactivity suggestive of an underlying pathogenic mutation20, while PD-L1 and AR immunostains were negative (Fig. 1c). This evidence concerns the gene TP53 and neoplasm.